- Enzymes
- Instruments
- Kits
- Reagents
Glycomics Market size was valued at USD 924.5 million in 2022 and is projected to grow at a 15.3% CAGR from 2023 to 2029. The study of saccharides, which are extensively found in nature and are also thought of as glycans, and their structure, biology, and function is known as glycomics or glycobiology. Most proteins are revised after the translation process in eukaryotic cells. The attachment of glycans is one of the most usual modifications for cell viability. The Enzymes segment is anticipated to grow at a significant CAGR over the forecast years due to the consumable nature of enzymes and their wide applications in a variety of R&D and drug discovery procedures. The glycose of a tissue, cell, or organism can be quantified or defined using a variety of research techniques in Glycosmis. The final glycan structure changes because of changes in location or the activity of the enzymes involved in glycan production. As a result, in addition to genetic markers for people, glycan analysis may be used to evaluate alterations brought on by the environment. This research can be used to find new medicines and diagnose diseases. One of the main drivers of segment expansion is this. Increase in demand for research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth in the proteomics market. On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment are a few factors driving the industry's growth over the forecasting period.
Glycomics Market Key Developments:
- In June 2019, Agilent Technologies (US) has launched InfinityLab LC/MSD iQ System.
- In June 2018, Thermo Fisher Scientific (US) had launched UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer.
Glycomics Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
15.3%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Glycomics Market Dynamics
The rising government funding in research and the creation of innovative treatments by pharmaceutical and biotechnology businesses. Furthermore, increased interest in glycomics and proteomics research investigations is expected to drive market development in the forcasting period. Rising government and organisation investments have enabled university researchers to create novel glycomics and glycobiology technologies. This aspect is expected to propel the glycomics market, and therefore the total industry. Advanced analytical approaches for understanding pathogen and human glycobiology in illness and health are required in glycoproteomic. Hence, there has been a rise in biomedical and proteomics research, leading to the growth of this market.
Asia-Pacific Got Significant Share
Glycomics Market Regional Analysis
The Glycomics market in North America is likely to hold the highest revenue share of in 2023 and same trend is expected over the forecast period owing to untapped market opportunities. Evolving pharmaceutical and biopharmaceutical industries have resulted in immense growth of glycomics in the region. In addition, investments by Contract Research Organizations (CROs) for the development and production of drugs and biologics are expected to fuel growth of the Asia Pacific glycomics market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Glycomics Market Segmentation
By Product Type
By Application
- Diagnostics
- Drug Discovery & Development
- Oncology, Immunology
- Other Applications
By End User
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
By Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
LOCATION
Geography
Frequently Asked Questions
The glycomics market size was valued at USD 924.5 million in 2022
The glycomics market key players are: Merck KGaA (Germany) Agilent Technologies (US) Thermo Fisher Scientific (US) New England Biolabs (US) Shimadzu Corporation (Japan) Takara Bio (Japan) S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan) Waters Corporation (US) Asparia Glycomics S.L. (Spain) Bio-Techne (US) Bruker Corporation (US) Danaher Corporation (US) RayBiotech (US) Z Biotech (US) Chemily Glycoscience (US)
The glycomics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The glycomics market size was valued at USD 924.5 million in 2022
The glycomics market key players are: Merck KGaA (Germany) Agilent Technologies (US) Thermo Fisher Scientific (US) New England Biolabs (US) Shimadzu Corporation (Japan) Takara Bio (Japan) S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan) Waters Corporation (US) Asparia Glycomics S.L. (Spain) Bio-Techne (US) Bruker Corporation (US) Danaher Corporation (US) RayBiotech (US) Z Biotech (US) Chemily Glycoscience (US)
The glycomics market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Glycomics Market Introduction |
| 2.1.Global Glycomics Market - Taxonomy |
| 2.2.Global Glycomics Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3. End User |
| 2.2.4.Geography |
| 2.2.5.Region |
| 3. Global Glycomics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Glycomics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Glycomics Market By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Enzymes |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Kits |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Reagents |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Glycomics Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Diagnostics |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Drug Discovery & Development |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Oncology, Immunology |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Other Applications |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Glycomics Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Academic Research Institutes |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Pharmaceutical & Biotechnology Companies |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Contract Research Organizations |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Glycomics Market By Geography, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. The Asia Pacific |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. MEA |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Global Glycomics Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Glycomics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Enzymes |
| 10.1.2.Instruments |
| 10.1.3.Kits |
| 10.1.4.Reagents |
| 10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Diagnostics |
| 10.2.2.Drug Discovery & Development |
| 10.2.3.Oncology, Immunology |
| 10.2.4.Other Applications |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Academic Research Institutes |
| 10.3.2.Pharmaceutical & Biotechnology Companies |
| 10.3.3.Contract Research Organizations |
| 10.4. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.North America |
| 10.4.2.Europe |
| 10.4.3.The Asia Pacific |
| 10.4.4.Latin America |
| 10.4.5.MEA |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Glycomics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Enzymes |
| 11.1.2.Instruments |
| 11.1.3.Kits |
| 11.1.4.Reagents |
| 11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Diagnostics |
| 11.2.2.Drug Discovery & Development |
| 11.2.3.Oncology, Immunology |
| 11.2.4.Other Applications |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Academic Research Institutes |
| 11.3.2.Pharmaceutical & Biotechnology Companies |
| 11.3.3.Contract Research Organizations |
| 11.4. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.North America |
| 11.4.2.Europe |
| 11.4.3.The Asia Pacific |
| 11.4.4.Latin America |
| 11.4.5.MEA |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12. Asia Pacific (APAC) Glycomics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Enzymes |
| 12.1.2.Instruments |
| 12.1.3.Kits |
| 12.1.4.Reagents |
| 12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Diagnostics |
| 12.2.2.Drug Discovery & Development |
| 12.2.3.Oncology, Immunology |
| 12.2.4.Other Applications |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Academic Research Institutes |
| 12.3.2.Pharmaceutical & Biotechnology Companies |
| 12.3.3.Contract Research Organizations |
| 12.4. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.North America |
| 12.4.2.Europe |
| 12.4.3.The Asia Pacific |
| 12.4.4.Latin America |
| 12.4.5.MEA |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Glycomics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Enzymes |
| 13.1.2.Instruments |
| 13.1.3.Kits |
| 13.1.4.Reagents |
| 13.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Diagnostics |
| 13.2.2.Drug Discovery & Development |
| 13.2.3.Oncology, Immunology |
| 13.2.4.Other Applications |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Academic Research Institutes |
| 13.3.2.Pharmaceutical & Biotechnology Companies |
| 13.3.3.Contract Research Organizations |
| 13.4. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.North America |
| 13.4.2.Europe |
| 13.4.3.The Asia Pacific |
| 13.4.4.Latin America |
| 13.4.5.MEA |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Glycomics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Enzymes |
| 14.1.2.Instruments |
| 14.1.3.Kits |
| 14.1.4.Reagents |
| 14.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Diagnostics |
| 14.2.2.Drug Discovery & Development |
| 14.2.3.Oncology, Immunology |
| 14.2.4.Other Applications |
| 14.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Academic Research Institutes |
| 14.3.2.Pharmaceutical & Biotechnology Companies |
| 14.3.3.Contract Research Organizations |
| 14.4. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.North America |
| 14.4.2.Europe |
| 14.4.3.The Asia Pacific |
| 14.4.4.Latin America |
| 14.4.5.MEA |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Merck KGaA (Germany) |
| 15.2.2.Agilent Technologies (US) |
| 15.2.3.Thermo Fisher Scientific (US) |
| 15.2.4.New England Biolabs (US) |
| 15.2.5.Shimadzu Corporation (Japan) |
| 15.2.6.Takara Bio (Japan) |
| 15.2.7.S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan) |
| 15.2.8.Waters Corporation (US) |
| 15.2.9.Asparia Glycomics S.L. (Spain) |
| 15.2.10.Bio-Techne (US) |
| 15.2.11.Bruker Corporation (US) |
| 15.2.12.Danaher Corporation (US) |
| 15.2.13.RayBiotech (US) |
| 15.2.14.Z Biotech (US) |
| 15.2.15.Chemily Glycoscience (US) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Merck KGaA (Germany)
- Agilent Technologies (US)
- Thermo Fisher Scientific (US)
- New England Biolabs (US)
- Shimadzu Corporation (Japan)
- Takara Bio (Japan)
- S-BIO (subsidiary of Sumitomo Bakelite Co. Ltd., Japan)
- Waters Corporation (US)
- Asparia Glycomics S.L. (Spain)
- Bio-Techne (US)
- Bruker Corporation (US)
- Danaher Corporation (US)
- RayBiotech (US)
- Z Biotech (US)
- Chemily Glycoscience (US)